Deborah A Forst1, Alyx F Podgurski2, Kit M Quain2, Sophia L Landay2, Maya Anand2, Emilia Kaslow-Zieve2, Michelle M Mesa2, Jamie M Jacobs3, Jorg Dietrich4, Michael W Parsons3, Nora Horick5, Joseph A Greer3, Tracy T Batchelor6, Vicki A Jackson2, Areej El-Jawahri2, Jennifer S Temel2. 1. Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Yawkey 9E, Boston, MA, 02114, USA. dforst@partners.org. 2. Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA. 3. Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. 4. Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Yawkey 9E, Boston, MA, 02114, USA. 5. Massachusetts General Hospital Biostatistics Center, Boston, MA, USA. 6. Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
Abstract
PURPOSE: Caregivers of patients with malignant gliomas are at risk for psychological distress. However, factors associated with distress in this population have not been well described. We conducted a prospective study evaluating psychological distress in patients with malignant gliomas and their caregivers and exploring factors associated with caregiver distress. METHODS: We enrolled patients with newly diagnosed malignant gliomas (N = 77) and their caregivers (N = 61). At baseline and 3, 6, and 9 months after diagnosis, we administered the Hospital Anxiety and Depression Scale to assess psychological distress and the Caregiver Reaction Assessment to evaluate caregiver burden. We performed multivariable regression analyses to investigate caregiver-related, patient-related, and tumor-related factors associated with caregivers' distress. RESULTS: At baseline, 48.3% (29/60) and 26.2% (16/61) of caregivers reported clinically significant anxiety and depression symptoms, respectively. Anxiety and depression symptoms persisted over time. Greater caregiver depression was associated with male gender (B = 1.48, 95% CI 0.16-2.81, p = 0.03), higher caregiver burden (B = 0.08, 95% CI 0.01-0.15, p = 0.02), caregiver anxiety (B = 0.53, 95% CI 0.38-0.68, p < 0.0001), patient depression (B = 0.34, 95% CI 0.13-0.55, p = 0.002), and caring for a younger patient (B = -0.07, 95% CI -0.15 to 0.00, p = 0.049). Factors associated with greater caregiver anxiety symptoms were caregiver depression (B = 0.91, 95% CI 0.71-1.12, p < 0.0001) and younger patient age (B = -0.15, 95% CI -0.24 to -0.05, p = 0.003). CONCLUSION: Male gender, higher caregiver burden, greater patient depression symptoms, and younger patient age are associated with increased distress among caregivers of patients with malignant gliomas, underscoring the need for tailored supportive care interventions targeting caregivers at highest risk for psychological distress.
PURPOSE: Caregivers of patients with malignant gliomas are at risk for psychological distress. However, factors associated with distress in this population have not been well described. We conducted a prospective study evaluating psychological distress in patients with malignant gliomas and their caregivers and exploring factors associated with caregiver distress. METHODS: We enrolled patients with newly diagnosed malignant gliomas (N = 77) and their caregivers (N = 61). At baseline and 3, 6, and 9 months after diagnosis, we administered the Hospital Anxiety and Depression Scale to assess psychological distress and the Caregiver Reaction Assessment to evaluate caregiver burden. We performed multivariable regression analyses to investigate caregiver-related, patient-related, and tumor-related factors associated with caregivers' distress. RESULTS: At baseline, 48.3% (29/60) and 26.2% (16/61) of caregivers reported clinically significant anxiety and depression symptoms, respectively. Anxiety and depression symptoms persisted over time. Greater caregiver depression was associated with male gender (B = 1.48, 95% CI 0.16-2.81, p = 0.03), higher caregiver burden (B = 0.08, 95% CI 0.01-0.15, p = 0.02), caregiver anxiety (B = 0.53, 95% CI 0.38-0.68, p < 0.0001), patient depression (B = 0.34, 95% CI 0.13-0.55, p = 0.002), and caring for a younger patient (B = -0.07, 95% CI -0.15 to 0.00, p = 0.049). Factors associated with greater caregiver anxiety symptoms were caregiver depression (B = 0.91, 95% CI 0.71-1.12, p < 0.0001) and younger patient age (B = -0.15, 95% CI -0.24 to -0.05, p = 0.003). CONCLUSION: Male gender, higher caregiver burden, greater patient depression symptoms, and younger patient age are associated with increased distress among caregivers of patients with malignant gliomas, underscoring the need for tailored supportive care interventions targeting caregivers at highest risk for psychological distress.
Authors: Georgia K B Halkett; Elizabeth A Lobb; Thèrése Shaw; Michelle M Sinclair; Lisa Miller; Elizabeth Hovey; Anna K Nowak Journal: Support Care Cancer Date: 2016-11-14 Impact factor: 3.603
Authors: Florien W Boele; Jan J Heimans; Neil K Aaronson; Martin J B Taphoorn; Tjeerd J Postma; Jaap C Reijneveld; Martin Klein Journal: J Neurooncol Date: 2013-07-04 Impact factor: 4.130
Authors: B Russell; A Collins; A Dowling; M Dally; M Gold; M Murphy; J Burchell; J Philip Journal: Support Care Cancer Date: 2015-04-25 Impact factor: 3.603
Authors: Erin E Kent; Michelle A Mollica; J Nicholas Dionne-Odom; Rebecca A Ferrer; Roxanne E Jensen; Katherine A Ornstein; Ashley Wilder Smith Journal: Palliat Support Care Date: 2020-10
Authors: Anna Collins; Carrie Lethborg; Caroline Brand; Michelle Gold; Gaye Moore; Vijaya Sundararajan; Michael Murphy; Jennifer Philip Journal: BMJ Support Palliat Care Date: 2013-06-01 Impact factor: 3.568